Microdose Gummies with Psilocybin and other psychedelics have exploded in popularity. Many people use them to improve their mental health and to overcome addictions to drugs like alcohol, tobacco, and opioids. The practice is known as microdosing, and advocates say it offers a wide range of benefits, from enhanced creativity to reduced depression symptoms. Among the most popular ways to consume mushrooms is through gummies, which combine compounds from psilocybin-containing mushrooms with other ingredients in a sweet treat that can be easily ingested and digested.

Unfortunately, many of these gummies contain dangerous additives that may cause serious harm to consumers. For example, one popular brand of gummies called Diamond Shruumz recalled 22 different products last June. These included infused chocolate bars, gummies, and more. In some of these gummies, toxicology experts found unlabeled psilocybin and a dangerous compound called muscimol. Unlike psilocybin, muscimol is not a Schedule I drug, but it can cause hallucinations and other harmful side effects.

Explore Microdose Mushroom Options Available in Canada

It is also difficult to know what is actually in these gummies because there is no regulatory oversight or quality control of these products. Instead, most sellers are using online marketplaces to sell these products, and these marketplaces lack the safeguards that protect consumers from illegal drugs like psilocybin. The gummies often do not contain the amount of psilocybin they advertise, and they are likely to have many other unlabeled ingredients as well.

If an employee is discovered to be microdosing psilocybin while at work, employers should have carefully written policies that articulate the types of impairment that could result from the use of this drug. Employers should also have a robust employee assistance program to help workers manage their personal issues, including psychedelic use.